Australia begins crackdown on vaping, to ban import of single-use devices
Sign up now: Get ST's newsletters delivered to your inbox
Around one in five people aged 18 to 24 vapes, according to government data.
PHOTO: REUTERS
Follow topic:
SYDNEY – Australia will ban imports of disposable vapes in January 2024, the health minister said on Nov 28, the first step in a crackdown aimed at curbing the growing popularity of these nicotine-filled devices
The ban will be expanded in March 2024 to include all non-therapeutic vapes, including refillable devices, while importers of vapes for medical purposes will need a permit from the Office of Drug Control, Health Minister Mark Butler said in a statement.
The legislative package will also include a total of A$75 million (S$66 million) in extra funding for the Australian Border Force and the Therapeutic Goods Administration to enforce the new rules.
Additional legislation will apply the same prohibitions to domestic manufacturers in 2024.
“These are the vapes that have pink unicorns on them, bubblegum flavouring, disguised in order for them to hide them in their pencil cases,” Mr Butler told a news conference.
“This is not a therapeutic good to help hardened smokers kick the habit. This is a good that is deliberately targeted at kids to recruit them to nicotine addiction.”
Despite Australia having one of the lowest rates of smoking in the Organisation for Economic Cooperation and Development, a group of mostly rich countries, vaping in Australia is growing rapidly, especially among the young.
Around one in five people aged 18 to 24 vapes, according to government data.
First flagged in August, the reforms aim to curb the device’s popularity in response to research showing the potential for long-term harm.
To ensure the bans do not limit access for smokers looking to quit, doctors and nurses will be given expanded powers in January 2024 to prescribe therapeutic vapes where clinically appropriate.
But therapeutic vapes will be restricted from using flavours, have limited nicotine levels and be sold in pharmaceutical packaging under new rules to be introduced in 2024, with a transition period for manufacturers to comply. REUTERS
